CHO Pharma, Inc. (TPEX:6586)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
39.95
-0.45 (-1.13%)
Jul 22, 2025, 1:51 PM CST
-38.44%
Market Cap8.55B
Revenue (ttm)3.58M
Net Income (ttm)-212.23M
Shares Out214.01M
EPS (ttm)-0.99
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume217,347
Average Volume308,096
Open39.85
Previous Close39.95
Day's Range39.00 - 40.15
52-Week Range37.50 - 68.80
Beta-0.47
RSI44.08
Earnings DateAug 7, 2025

About CHO Pharma

CHO Pharma, Inc., engages in research and development of biotechnology in Taiwan. It develops glycoengineering platform technologies, including SAR-based glycoengineered biobetters; glycosite-specific antibody-drug conjugates (ADCs); novel antibodies and vaccines targeting novel carbohydrate antigens; and programs using its glycoengineering technologies. The company also provides CHOptimax, an in vitro enzymatic one-pot process that converts naked antibodies into glycoengineered biobetter or ADC. In addition, the company develops CHO-H01, which... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6586
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.